Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Proteome Sciences Plc (PRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7043
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc (PRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteome Sciences Plc, Medical Equipment, Deal Details 10
Partnerships 10
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Equity Offering 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc – Key Competitors 17
Proteome Sciences Plc – Key Employees 18
Proteome Sciences Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 21
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 24
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 29
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 30
Corporate Communications 41
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 41
Aug 01, 2017: Proteome Sciences: Directorate changes 42
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 43
Legal and Regulatory 44
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 44
Jun 12, 2017: Proteome Sciences: New Registered Address 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Proteome Sciences Plc, Medical Equipment, Key Facts, 2017 2
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc, Key Competitors 17
Proteome Sciences Plc, Key Employees 18
Proteome Sciences Plc, Other Locations 19
Proteome Sciences Plc, Subsidiaries 19

List of Figures
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gulf Resources, Inc. (GURE):企業の財務・戦略的SWOT分析
    Gulf Resources, Inc. (GURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Del Taco Holdings, Inc.:戦略・SWOT・企業財務分析
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vitrolife AB (VITR):医療機器:M&Aディール及び事業提携情報
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation …
  • North Central Electric Cooperative, Inc.:企業の戦略的SWOT分析
    North Central Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Touchstone Group plc:企業の戦略的SWOT分析
    Touchstone Group plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kennametal Inc.:企業の戦略・SWOT・財務情報
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Propanc Biopharma Inc (PPCB):製薬・医療:M&Aディール及び事業提携情報
    Summary Propanc Biopharma Inc (Propanc), formerly Propanc Health Group Corp, is a clinical stage biopharmaceutical company, which manufactures products for the treat of metastatic, pancreatic, ovarian and colorectal cancers. The company’s lead product candidate, PRP, a once-a-day intravenous formula …
  • Actelion Ltd:企業の戦略・SWOT・財務情報
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tenaris SA:戦略・SWOT・企業財務分析
    Tenaris SA - Strategy, SWOT and Corporate Finance Report Summary Tenaris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Avis Budget Group, Inc.:戦略・SWOT・企業財務分析
    Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Waters Corp (WAT):企業の財務・戦略的SWOT分析
    Waters Corp (WAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Internet Brands, Inc.:企業のM&A・事業提携・投資動向
    Internet Brands, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Internet Brands, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • EnSync Inc (ESNC):電力:M&Aディール及び事業提携情報
    Summary Ensync Inc (Ensync), formerly ZBB Energy Corp, is a technology solutions company that develops and markets energy management systems. The company provides products such as energy management, internet of energy, energy storage, system support, system design and resources, among others. Its en …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mediq NV:企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Comet Ridge Ltd (COI):企業の財務・戦略的SWOT分析
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • Emera Inc.:企業の戦略・SWOT・財務情報
    Emera Inc. - Strategy, SWOT and Corporate Finance Report Summary Emera Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆